initial public offerings (IPOs) trading on American exchanges

Tuesday, May 5, 2020

Ayala Pharmaceuticals (AYLA) sets IPO terms

Ayala Pharmaceuticals (AYLA) has filed an updated preliminary prospectus for its IPO of ~3.3M common shares at $14 - 16 per share.
Underwriters' over-allotment will be up to an additional 500K shares.

The Rehovet, Israel-based biopharmaceutical outfit develops treatments for rare and aggressive cancers by leveraging its bioinformatics platform and next-gen sequencing.

No comments:

Post a Comment